<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-4461943015255529"
     crossorigin="anonymous"></script>
<!-- resp exc new -->
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-4461943015255529"
     data-ad-slot="6783568728"
     data-ad-format="auto"
     data-full-width-responsive="true"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
  • October 24, 2021

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

Feature
  • August 4, 2020

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune

New Delhi, August 04, 2020. The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine. India continues to improve the…
Live Updates COVID-19 CASES